Form 8-K - Current report:
SEC Accession No. 0001564590-21-028692
Filing Date
2021-05-18
Accepted
2021-05-18 16:01:50
Documents
16
Period of Report
2021-05-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K scyx-8k_20210517.htm   iXBRL 8-K 54653
2 EX-1.1 scyx-ex11_6.htm EX-1.1 288139
3 EX-1.2 scyx-ex12_7.htm EX-1.2 285777
4 EX-5.1 scyx-ex51_34.htm EX-5.1 15700
5 GRAPHIC gjk1p4hqdk1j000001.jpg GRAPHIC 2008
  Complete submission text file 0001564590-21-028692.txt   897834

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA scyx-20210517.xsd EX-101.SCH 5776
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE scyx-20210517_lab.xml EX-101.LAB 19478
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scyx-20210517_pre.xml EX-101.PRE 11630
9 EXTRACTED XBRL INSTANCE DOCUMENT scyx-8k_20210517_htm.xml XML 3544
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

IRS No.: 562181648 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36365 | Film No.: 21935915
SIC: 2834 Pharmaceutical Preparations